Quick Overview: Christopher Reardon, Dyno Therapeutics, Cambridge, MA, provides his Take a sneak peak at some of the action from Nathalie Clement, PhD, Unicorn Consultations, Gainesville, FL, provides some of her

Highlights From Advanced Therapies Week - Detailed Overview & Context

Christopher Reardon, Dyno Therapeutics, Cambridge, MA, provides his Take a sneak peak at some of the action from Nathalie Clement, PhD, Unicorn Consultations, Gainesville, FL, provides some of her Natalia Elizalde Discusses the Challenges of Viral Vectors In this video interview, Natalia Elizalde discusses the use of lentiviral ... Dr. Abdulkader Rahmo, PhD, President of SMSbiotech, delivers his keynote presentation, “Exploring Novel Cell Sources to ... Jeff Liter, MBA, Luminary Therapeutics, Minneapolis, MN, provides his

How Do We as an Industry Support Rare & Ultra-Rare Disease? ATW 2025 With millions affected by rare and ultra-rare diseases, ... Opening Plenary: The Future of Cell & Gene Stuart Gibb On The Importance of Collaboration Why CDMOs, Solution Providers & Consultants Shouldn't Miss Kim Barnes on Post-Pandemic Pharma Events A lot has changed in trade shows and conferences since 2019. In this video, we ... Book your tickets now! Join Europe's Largest Cell & Gene Conference. Thousands Of Attendees, 200+ World's Top Speakers, ...

Photo Gallery

Advanced Therapies Week 2025 Highlights Video
Advanced Therapies Week 2026 Highlights | The Future of Cell & Gene Therapy
Highlights from Advanced Therapies Week 2022
Highlights from Advanced Therapies Week 2022
Key highlights at Advanced Therapies Week 2022
Advanced Therapies Week - Phacilitate. Natalie Elizalde, Chief Business Development, VIVEBiotech
Advanced Therapies Week 2026: Dr. Rahmo on Novel Cell Sources in Cell Therapy
Allogeneic therapy highlights at Advanced Therapies Week 2022
Advanced Therapies Week 2025: How Do We As An Industry Support Rare Ultra Rare Disease
Advanced Therapies Week 2025: Opening Plenary
Inside Advanced Therapies Week 2026 | Where the Cell & Gene Therapy World Connects
Advanced Therapies Week - Phacilitate. Stuart Gibb Head of Scientific Strategy CGT, Terumo
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored